Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,103 | 85,789 | 73,065 | 43,506 | 45,913 |
| Marketable Securities | 75,589 | 130,105 | 151,262 | 177,622 | 213,915 |
| Receivables | 9,298 | 9,182 | 9,489 | 7,210 | 9,747 |
| TOTAL | $206,760 | $230,284 | $237,303 | $234,395 | $275,134 |
| Non-Current Assets | |||||
| PPE Net | 7,862 | 6,626 | 6,032 | 5,471 | 5,163 |
| Investments And Advances | 0 | 0 | 20,505 | 54,312 | 36,526 |
| Other Non-Current Assets | 3,908 | 3,956 | 849 | 872 | 935 |
| TOTAL | $11,770 | $10,582 | $27,386 | $60,655 | $42,624 |
| Total Assets | $218,530 | $240,866 | $264,689 | $295,050 | $317,758 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,259 | 4,276 | 7,555 | 8,904 | 9,678 |
| Accrued Expenses | 18,358 | 21,259 | 14,622 | 14,289 | 13,297 |
| Other current liabilities | 0 | 0 | 1,249 | 1,249 | 1,249 |
| TOTAL | $34,666 | $29,131 | $25,049 | $34,609 | $31,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,624 | 23,933 | 25,800 | 15,619 | 17,900 |
| Deferred Revenues | 1,715 | 1,650 | 1,623 | 1,616 | 1,554 |
| Other Non-Current Liabilities | 1,238 | 1,238 | 1,238 | 1,238 | 1,238 |
| TOTAL | $45,672 | $45,903 | $46,733 | $36,900 | $39,540 |
| Total Liabilities | $80,338 | $75,034 | $71,782 | $71,509 | $71,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,373 | 4,367 | 4,357 | 4,356 | 4,320 |
| Common Shares | 44 | 44 | 44 | 43 | 43 |
| Retained earnings | -298,780 | -268,658 | -239,112 | -205,866 | -180,697 |
| Other shareholders' equity | -9 | 9 | 60 | -167 | -296 |
| TOTAL | $138,192 | $165,832 | $192,907 | $223,541 | $246,298 |
| Total Liabilities And Equity | $218,530 | $240,866 | $264,689 | $295,050 | $317,758 |